Gene-gene and gene-clinical factors interaction in acute myocardial infarction: A new detailed risk chart

Current Pharmaceutical Design

Volumn 16, Issue 7, 2010, Pages 783-788

  Licastro, F ^a   Chiappelli, M ^a   Porcellini, E ^a   Campo, G ^b   Buscema, M ^c   Grossi, E ^d   Garoia, F ^e   Ferrari, R ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c Semeion centro ricerche di scienze della communicazione   (Italy)

^d Bracco SpA   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

Author keywords

Acute myocardial infarction; Connectivity map; Gene risk factor interaction

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; GAMMA INTERFERON; GLYCOPROTEIN; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL SYNTHESIS; FEMALE; GENE INTERACTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; AGE FACTORS; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 77950229119     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883543     Document Type: Article

References (36)

1. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88: 119-124
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753
3. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-1369
4. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 1999; 130: 933-937
5. Cummings DM, King DE, Mainous AG, Geesey ME. Combining serum biomarkers: the association of C-reactive protein, insuline sensitivity, and homocysteine with cardiovascular disease history in the general US population. Eur J Cardiovasc Prev Rehabil 2006; 13: 180-185
6. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Atherioscler Thromb Vasc Biol 1995; 15: 1263-1268
7. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001; 47: 403-411
8. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, et al. Opposite effects of Interleukin-10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004; 41: 790-794
9. Licastro F, Chiappelli M, Caldarera CM, Tampieri C, Nanni S, Gallina M, et al. The concomitant presence of polymorphic alleles of Interleukin-1 beta, Interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 2004; 125: 575-579
10. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-2153
11. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Calderera CM, Nanni S, et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005; 32: 349-353
12. Kullo IJ, Ding K. Mechanisms of disease: the genetic basis of coronary heart disease. Nat Clin Pract Cardiovasc Med 2007; 4: 558-569
13. Hamsten A, Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Inter Med 2008; 263: 538-552
14. Buscema M, Grossi E. The semantic connectivity map: an adapting self-organizing knowledge discovery method in data bases. Experience in gastro-esophageal reflux disease. Int J Data Min Bioinform 2008; 2: 362-404.
15. Licastro F, Porcellini E, Chiappelli M, Forti P, Buscema M, Ravaglia G, et al. Multivariable network associated with cognitive decline and dementia. Neurobiol Aging 2008; [Epub ahead of print].
16. Ravaglia G, Forti P, Maioli F, Orlanducci P, Sacchetti L, Flisi E, et al. Conselice study: a population based survey of brain aging in a municipality of the Emilia Romagna region: (A.U.S.L. Ravenna). Design and methods. Arch Gerontol Geriatr Suppl 2001; 7: 313-324
17. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, et al. Association of early-onset Alzheimer's disease with an interkleukin-1 alpha polymorphism. Ann Neurol 2000; 47: 361-365
18. Latorra D, Campbell K, Wolter A, Hurley JM. Enhanced allelespecific PCR discrimination in SNP genotyping using 3′ Locked Nucleic Acid (LNA) primers. Hum Mutat 2003; 2: 79-85.
19. Olivieri F, Antonicelli R, Cardelli M, Marchegiani F, Cavallone L, Mocchegiani E, et al. Genetic polymorphisms of inflammatory cytokines and myocardial infarction in the elderly. Mech Ageing Dev 2006; 127: 552-559
20. Kock W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schoming A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159: 137-144
21. Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, et al. New polymorphisms in the interleukin-10 gene - relationships to myocardial infarction. Eur J Clin Invest 2001; 31: 9-14.
22. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006; 187: 408-414
23. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middleaged men. Atherosclerosis 2001; 154: 691-697
24. Howell WM, Ali S, Rose-Zerilli MJ, Ye S. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005; 42: 485-490
25. Morgan K, Licastro F, Tilley L, Ritchie A, Morgan L, Pedrini S, et al. Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentration. Hum Genet 2001; 109: 303-310
26. Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mulè AL, et al. Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am J Gastroenterol 2003; 98: 850-856
27. Lio D, Scola L, Crivello A, Bonafè M, Franceschi C, Olivieri F, et al. Allele frequencies o +874T->A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 2002; 37: 315-319
28. Licastro F, Grimaldi LM, Bonafè M, Martina C, Olivieri F, Cavallone L, et al. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels on the cytokine in blood and brain. Neurobiol Aging 2003; 24: 921-926
29. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232-1235
30. Kruskal JB. On the shortest spanning subtree of a graph and the travelling-salesman problem. Proc Am Math Soc 1956; 7: 48-50.
31. Haslinger-Loffler B. Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function. Kidney Int 2008; 74: 553-555
32. De Ruijter W, Westendorp RDJ, Assendelft WJJ, den Elzen WPJ, de Craen AJM, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2008 [Epub ahead of print].
33. Zhao SP, Dong SZ. Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin Chim Acta 2008; 389: 67-71.
34. Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josee RG, et al. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo AI concentrations. Am J Clin Nutr 2007; 86: 768-774
35. Sonoda S, Chino N, Domen K, Saitoh E. Changes in impairment and disability from the third to the sixth month after stroke and its relationship evaluated by an artificial neural network. Am J Phys Med Rehabil 1997; 76: 395-400.
36. Kaczmarczyk K, Wit A, Krawczyk M, Zaborski J. Gait classification in post-stroke patients using artificial neural networks. Gait Posture 2009; 30: 207-210